Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 3 of 16 for:    Gantenerumab

A Study to Evaluate the Pharmacodynamic (PD) Effects of Once Weekly Administration of Gantenerumab in Participants With Early Alzheimer's Disease (AD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04592341
Recruitment Status : Active, not recruiting
First Posted : October 19, 2020
Last Update Posted : October 12, 2021
Sponsor:
Information provided by (Responsible Party):
Hoffmann-La Roche

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : October 27, 2023
Estimated Study Completion Date : February 16, 2024